These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34039823)

  • 1. Prognostic Impact of Calcified Plaque Morphology After Drug Eluting Stent Implantation　- An Optical Coherence Tomography Study.
    Iwai S; Watanabe M; Okamura A; Kyodo A; Nogi K; Kamon D; Hashimoto Y; Ueda T; Soeda T; Okura H; Saito Y
    Circ J; 2021 Oct; 85(11):2019-2028. PubMed ID: 34039823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
    Mitsui K; Lee T; Miyazaki R; Hara N; Nagamine S; Nakamura T; Terui M; Okata S; Nagase M; Nitta G; Watanabe K; Kaneko M; Nagata Y; Nozato T; Ashikaga T
    Catheter Cardiovasc Interv; 2023 Jul; 102(1):11-17. PubMed ID: 37210618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical outcome of rotational atherectomy followed by drug-eluting stent implantation in complex calcified coronary lesions.
    Abdel-Wahab M; Baev R; Dieker P; Kassner G; Khattab AA; Toelg R; Sulimov D; Geist V; Richardt G
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):285-91. PubMed ID: 22431433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Subclinical Intrastent Thrombus Detected 9 Months After Implantation of 2nd-Generation Drug-Eluting Stent With Future Major Adverse Cardiac Events　- A Coronary Angioscopic Study.
    Okuno S; Ishihara T; Iida O; Asai M; Masuda M; Okamoto S; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Takahara M; Uematsu M; Mano T
    Circ J; 2018 Aug; 82(9):2299-2304. PubMed ID: 29973431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of target lesion revascularisation after drug-eluting stent implantation for calcified nodules: an optical coherence tomography study.
    Hamana T; Kawamori H; Toba T; Kakizaki S; Nakamura K; Fujimoto D; Sasaki S; Fujii H; Osumi Y; Fujioka T; Nishimori M; Kozuki A; Shite J; Iwasaki M; Takaya T; Hirata KI; Otake H
    EuroIntervention; 2023 Jun; 19(2):e123-e133. PubMed ID: 36876497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule.
    Sugane H; Kataoka Y; Otsuka F; Nakaoku Y; Nishimura K; Nakano H; Murai K; Honda S; Hosoda H; Matama H; Doi T; Nakashima T; Fujino M; Nakao K; Yoneda S; Tahara Y; Asaumi Y; Noguchi T; Kawai K; Yasuda S
    Atherosclerosis; 2021 Feb; 318():70-75. PubMed ID: 33243488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical Coherence Tomography Comparison of Percutaneous Coronary Intervention Among Plaque Rupture, Erosion, and Calcified Nodule in Acute Myocardial Infarction.
    Khalifa AKM; Kubo T; Ino Y; Terada K; Emori H; Higashioka D; Katayama Y; Takahata M; Shimamura K; Shiono Y; Matsuo Y; Tanaka A; Hozumi T; Akasaka T
    Circ J; 2020 May; 84(6):911-916. PubMed ID: 32307358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    Giustino G; Mastoris I; Baber U; Sartori S; Stone GW; Leon MB; Serruys PW; Kastrati A; Windecker S; Valgimigli M; Dangas GD; Von Birgelen C; Smits PC; Kandzari D; Galatius S; Wijns W; Steg PG; Stefanini GG; Aquino M; Morice MC; Camenzind E; Weisz G; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Chieffo A; Mehran R
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1890-901. PubMed ID: 27659564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of post-stent optical coherence tomography findings among three subtypes of calcified culprit plaques in patients with acute coronary syndrome.
    Nakajima A; Araki M; Kurihara O; Minami Y; Soeda T; Yonetsu T; Crea F; Takano M; Higuma T; Kakuta T; Adriaenssens T; Lee H; Nakamura S; Jang IK
    Catheter Cardiovasc Interv; 2021 Mar; 97(4):634-645. PubMed ID: 32181576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular Response After Everolimus-Eluting Stent in Acute Myocardial Infarction Caused by Calcified Nodule.
    Ino Y; Takahata M; Kubo T; Khalifa AKM; Satogami K; Terada K; Ozaki Y; Katayama Y; Taruya A; Ota S; Wada T; Tanimoto T; Shiono Y; Kashiwagi M; Kuroi A; Tanaka A
    Circ J; 2022 Aug; 86(9):1388-1396. PubMed ID: 35545551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
    Généreux P; Bettinger N; Redfors B; Lee AC; Kim CY; Lee MS; Shlofmitz RA; Moses JW; Stone GW; Chambers JW
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):369-77. PubMed ID: 27084293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation.
    Guedeney P; Claessen BE; Mehran R; Mintz GS; Liu M; Sorrentino S; Giustino G; Farhan S; Leon MB; Serruys PW; Smits PC; von Birgelen C; Ali ZA; Généreux P; Redfors B; Madhavan MV; Ben-Yehuda O; Stone GW
    JACC Cardiovasc Interv; 2020 Jun; 13(12):1417-1428. PubMed ID: 32553329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Different Calcified Culprit Plaques in Patients with Acute Coronary Syndrome.
    Lei F; Yin Y; Liu X; Fang C; Jiang S; Xu X; Sun S; Pei X; Jia R; Tang C; Peng C; Li S; Li L; Wang Y; Yu H; Dai J; Yu B
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
    Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer-Generation Drug-Eluting Stents.
    Hemetsberger R; Abdelghani M; Toelg R; Mankerious N; Allali A; Garcia-Garcia HM; Windecker S; Lefèvre T; Saito S; Slagboom T; Kandzari D; Koolen J; Waksman R; Richardt G
    J Am Heart Assoc; 2021 Jun; 10(12):e019815. PubMed ID: 34056911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of angiographically insignificant suboptimal poststent findings detected by optical coherence tomography after drug-eluting stent implantation.
    Cho JY; Kook H; Yu CW
    PLoS One; 2020; 15(10):e0240860. PubMed ID: 33075066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ultra-long second-generation drug-eluting stent implantation.
    Honda Y; Muramatsu T; Ito Y; Sakai T; Hirano K; Yamawaki M; Araki M; Kobayashi N; Takimura H; Sakamoto Y; Mouri S; Tsutumi M; Takama T; Takafuji H; Tokuda T; Makino K
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):E44-53. PubMed ID: 26010548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optical coherence tomography factors for adverse events in patients with severe coronary calcification.
    Nagata T; Minami Y; Katsura A; Asakura K; Katamine M; Muramatsu Y; Fujiyoshi K; Kinoshita D; Ako J
    Int J Cardiol; 2023 Apr; 376():28-34. PubMed ID: 36804764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.